Development and optimization of osmotically controlled drug delivery system for poorly aqueous soluble diacerein to improve its bioavailability

References

• Zhang W, Moskowitz R, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162.
   PubMed Web of Science ®Google Scholar
• Rezende MUd, Gurgel H, Vilaça Junior PR, et al. Diacerhein versus glucosamine in a rat model of osteoarthritis. Clinics. 2006;61(5):461–466.
   PubMedGoogle Scholar
• Petrillo M, Montrone F, Ardizzone S, et al. Endoscopic evaluation of diacetylrhein-induced gastric mucosal lesions. Curr Ther Res. 1991;49(1):10–15.
   Web of Science ®Google Scholar
• Medhi B, Singh P, Prakash A, et al. Diacerein: a new disease modulating agent in osteoarthritis. IJPMR. 2007;18(2):48–52.
   Google Scholar
• Lorenz H, Richter W. Osteoarthritis: cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem. 2006;40(3):135–163.
   PubMedGoogle Scholar
• Moghddam SRM, Ahad A, Aqil M, et al. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. Mat Sci Eng: C. 2016;69:789–797.
   PubMed Web of Science ®Google Scholar
• Rehman M, Madni A, Ihsan A, et al. Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior. Int J Nanomed. 2015;10:2805.
   PubMed Web of Science ®Google Scholar
• Dörwald FZ. Lead optimization for medicinal chemists: pharmacokinetic properties of functional groups and organic compounds. Weinheim, Germany:John Wiley & Sons; 2012.
   Google Scholar
• Dabre R, Jain GK, Sandal R, et al. Pharmaceutical compositions of rhein or diacerein. Google Patents (Patent No. US 2010/0285114A1); 2010.
   Google Scholar
• Jain A, Singh SK, Singh Y, et al. Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects. J Biomed Nanotechnol. 2013;9(5):891–900.
   PubMed Web of Science ®Google Scholar
• Aggarwal AK, Singh S. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000. Drug Dev Ind Pharm. 2011;37(10):1181–1191.
   PubMed Web of Science ®Google Scholar
• Jin J, Sklar GE, Oh VMS, et al. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269.
   PubMedGoogle Scholar
• Yadav G, Bansal M, Thakur N, et al. Multilayer tablets and their drug release kinetic models for oral controlled drug delivery system. ME J Sci Res. 2013;16:782–795.
   Google Scholar
• Gupta BP, Thakur N, Jain NP, et al. Osmotically controlled drug delivery system with associated drugs. J Pharm Pharm Sci. 2010;13(4):571–588.
   PubMed Web of Science ®Google Scholar
• Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine: I. Cellulose acetate as a semipermeable membrane. J Controlled Release. 2003;89(1):5–18.
   PubMed Web of Science ®Google Scholar
• Verma RK, Kaushal AM, Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Int J Pharm. 2003;263(1-2):9–24.
   PubMed Web of Science ®Google Scholar
• Keraliya RA, Patel C, Patel P, et al. Osmotic drug delivery system as a part of modified release dosage form. ISRN Pharm. 2012;2012:1–9.
   Google Scholar
• Swanson DR, Barclay BL, Wong PS, et al. Nifedipine gastrointestinal therapeutic system. Am J Med. 1987;83(6):3–9.
   PubMedGoogle Scholar
• Wang C-Y, Ho H-O, Lin L-H, et al. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects. Int J Pharm. 2005;297(1-2):89–97.
   PubMed Web of Science ®Google Scholar
• Borgmann S, Parcianello L, Arend M, et al. Development and validation of a dissolution method with spectrophotometric analysis for diacerhein capsules. Sci Pharm. 2008;76(3):541–554.
   Google Scholar
• General Medical Council (Great Britain). British Pharmacopoeia. 2013;4:139–154.
   Google Scholar
• Singh SY, Shirodkar RK, Verma R, et al. Enhancement in dissolution rate of atorvastatin trihydrate calcium by formulating its porous tablet using sublimation technique. J Pharm Innov. 2019. doi:10.1007/s12247-019-09397-1
   Google Scholar
• El-Zahaby SA, Ghaly MHA, Abdelbary GA, et al. Development of a novel solid self-nano-emulsifying osmotically controlled system of a centrally acting drug: preparation and in-vitro evaluation. Inventi Impact NDDS. 2016;2016:35–49.
   Google Scholar
• Herbig S, Cardinal J, Korsmeyer R, et al. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Controlled Release. 1995;35(2-3):127–136.
   Web of Science ®Google Scholar
• Philip AK, Pathak K. Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility. Aaps Pharmscitech. 2006;7(3):E1–E11.
   PubMed Web of Science ®Google Scholar
• Nicolas P, Tod M, Padoin C, et al. Clinical pharmacokinetics of diacerein. Clin Pharmacokinet. 1998;35(5):347–359.
   PubMed Web of Science ®Google Scholar
• Layek B, Kumar TS, Trivedi RK, et al. Development and validation of a sensitive LC‐MS/MS method with electrospray ionization for quantitation of rhein in human plasma: application to a pharmacokinetic study. Biomed Chromatogr. 2008;22(6):616–624.
   PubMed Web of Science ®Google Scholar
• Elsayed I, Abdelbary AA, Elshafeey AH. Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. Int J Nanomedicine. 2014;9:2943–2953.
   PubMed Web of Science ®Google Scholar
• Oliveira CP, Ribeiro MEN, Ricardo NM, et al. The effect of water-soluble polymers, PEG and PVP, on the solubilisation of griseofulvin in aqueous micellar solutions of Pluronic F127. Int J Pharm. 2011;421(2):252–257.
   PubMed Web of Science ®Google Scholar
• Bouchemal K. New challenges for pharmaceutical formulations and drug delivery systems characterization using isothermal titration calorimetry. Drug Discovery Today. 2008;13(21-22):960–972.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. Vol. 6. London: Pharmaceutical Press; 2006.
   Google Scholar
• Yamashita K, Nakate T, Okimoto K, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm. 2003;267(1-2):79–91.
   PubMed Web of Science ®Google Scholar
• Sutradhar KB, Akhter DT, Uddin R. Formulation and evaluation of taste masked oral dispersible tablets of domperidone using sublimation method. Int J Pharm Pharm Sci. 2012;4(2):727–732.
   Google Scholar
• Conti S, Maggi L, Segale L, et al. Matrices containing NaCMC and HPMC: 2. Swelling and release mechanism study. Int J Pharm. 2007;333(1-2):143–151.
   PubMed Web of Science ®Google Scholar
• Thombre AG, Appel L, Chidlaw M, et al. Osmotic drug delivery using swellable-core technology. J Controlled Release. 2004;94(1):75–89.
   PubMed Web of Science ®Google Scholar
• Shokri J, Ahmadi P, Rashidi P, et al. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm. 2008;68(2):289–297.
   PubMed Web of Science ®Google Scholar
• Cath TY, Childress AE, Elimelech M. Forward osmosis: principles, applications, and recent developments. J Membr Sci. 2006;281(1-2):70–87.
   Web of Science ®Google Scholar
• Srinivas NSK, Verma R, Kulyadi GP, et al. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. IJN. 2016;12:15–28.
   Web of Science ®Google Scholar
• Ojha A, Rathod R, Padh H. Simultaneous HPLC–UV determination of rhein and aceclofenac in human plasma. J Chromatogr B. 2009;877(11-12):1145–1148.
   PubMed Web of Science ®Google Scholar
• Yaroshenko I, Khaimenov AY, Grigoriev A, et al. Determination of Rhein in blood plasma by HPLC with UV detection and its application to the study of bioequivalence. J Anal Chem. 2014;69(8):793–799.
   Web of Science ®Google Scholar
• Javed I, Hussain SZ, Shahzad A, et al. Lecithin-gold hybrid nanocarriers as efficient and pH selective vehicles for oral delivery of diacerein—in-vitro and in-vivo study. Colloids Surf, B. 2016;141:1–9.
   PubMed Web of Science ®Google Scholar
• Moffat AC, Osselton MD, Widdop B, et al. Clarke’s analysis of drugs and poisons. 4th ed. Vol. 2. London: Pharmaceutical press; 2011.
   Google Scholar
• Jain A, Mishra SK, Vuddanda PR, et al. Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Nanomed Nanotechnol Biol Med. 2014;10(5):e1031–e1040.
   PubMed Web of Science ®Google Scholar
• El-Laithy HM, Basalious EB, El-Hoseiny BM, et al. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: simultaneous portal blood absorption and lymphatic delivery. Int J Pharm. 2015;490(1–2):146–154.
   PubMed Web of Science ®Google Scholar